AGL 40.20 Decreased By ▼ -1.30 (-3.13%)
AIRLINK 129.11 Increased By ▲ 1.11 (0.87%)
BOP 6.60 Increased By ▲ 0.34 (5.43%)
CNERGY 4.03 Decreased By ▼ -0.10 (-2.42%)
DCL 8.45 Increased By ▲ 0.01 (0.12%)
DFML 41.25 Increased By ▲ 0.56 (1.38%)
DGKC 87.00 Decreased By ▼ -0.90 (-1.02%)
FCCL 33.35 Decreased By ▼ -0.75 (-2.2%)
FFBL 65.90 Decreased By ▼ -0.43 (-0.65%)
FFL 10.54 Decreased By ▼ -0.02 (-0.19%)
HUBC 110.70 Increased By ▲ 2.00 (1.84%)
HUMNL 15.23 Increased By ▲ 0.77 (5.33%)
KEL 4.78 Increased By ▲ 0.13 (2.8%)
KOSM 7.83 Increased By ▲ 0.50 (6.82%)
MLCF 41.90 Decreased By ▼ -0.82 (-1.92%)
NBP 60.50 Decreased By ▼ -0.34 (-0.56%)
OGDC 182.80 Increased By ▲ 3.83 (2.14%)
PAEL 25.36 Decreased By ▼ -0.34 (-1.32%)
PIBTL 6.26 Increased By ▲ 0.20 (3.3%)
PPL 147.81 Increased By ▲ 1.66 (1.14%)
PRL 24.56 Decreased By ▼ -0.35 (-1.41%)
PTC 16.24 Increased By ▲ 0.10 (0.62%)
SEARL 70.50 Increased By ▲ 0.30 (0.43%)
TELE 7.30 Increased By ▲ 0.08 (1.11%)
TOMCL 36.30 Increased By ▲ 0.10 (0.28%)
TPLP 7.85 Increased By ▲ 0.01 (0.13%)
TREET 15.30 Decreased By ▼ -0.29 (-1.86%)
TRG 51.70 Increased By ▲ 1.34 (2.66%)
UNITY 27.35 Increased By ▲ 0.45 (1.67%)
WTL 1.23 Decreased By ▼ -0.01 (-0.81%)
BR100 9,842 Increased By 47.4 (0.48%)
BR30 30,036 Increased By 389.6 (1.31%)
KSE100 92,520 Increased By 499.1 (0.54%)
KSE30 28,786 Increased By 121.7 (0.42%)
Business & Finance

Lahore based drug maker eyes to launch country’s biggest pharma IPO

  • As per Citi Pharma Chief Executive Officer Rizwan Ahmed, the pharma is expected to go public in a matter of six weeks.
Published February 19, 2021

In a bid to expand the company’s operations, Citi Pharma, the Lahore-based pharmaceutical plans to go public, in what is expected to be the biggest Initial Public Offering (IPO) by a pharmaceutical in Pakistan.

Seeking advantage of the rising trends at the Pakistan Stock Exchange (PSX), which was recently crowned among the best performing bourse in the world, Citi Pharma aims to raise over Rs 2.85 billion or USD18 million, reported Bloomberg.

The PSX started of 2021 on a bullish run as it emerged as the 2nd best performing market in the region and 7th best performing market in the world in the month of January.

“Historically we have seen healthy returns during the month of January and this month was no different. Infact KSE-100 returns (6.0%) have outperformed last 10-Yr average returns (4.1%) of January. The USD-based return for the month settled at 5.8%. 7MFY21 returns of the index have settled at 34.8% (USDbased: 41.4%),” stated Arif Habib Limited in its report.

Meanwhile, as per Citi Pharma Chief Executive Officer Rizwan Ahmed, the pharma is expected to go public in a matter of six weeks.

Back in 2018, pharmaceutical company AGP Limited successfully raised around Rs 2.8 billion from local, foreign and institutional investors'. Bids in book building were received in excess of Rs 5 billion. This OFS consisted of 35 million shares (20 million by OBS Pakistan and 15 million by Muller and Phipps Pakistan).

However, Citi Pharma wants to surpass AGP’s IPO target and as per the report plans to offer 35 percent of its equity by selling 72.7 million shares at Rs 28 per share.

The report stated that the company will use a majority chunk of its IPO funds to build a 50-bed hospital in Lahore, while the remaining be utilized to build two new plants, which will start operations by the end of this year.

Comments

Comments are closed.